Literature DB >> 19589299

Tuberculous meningitis in HIV-infected individuals.

Christopher Vinnard1, Rob Roy Macgregor.   

Abstract

HIV-infected individuals are at increased risk for all forms of extrapulmonary tuberculosis, including tuberculous meningitis. This risk is increased at more advanced levels of immunosuppression. The time interval between onset of symptoms and presentation to medical care may vary widely, and consequently individuals may present with acute or chronic meningitis. The clinical presentation of tuberculous meningitis in HIV-infected individuals is more likely to include an altered level of consciousness, cranial imaging is more likely to show cerebral infarctions, and the yield of culture of cerebrospinal fluid may also be greater. Given that delayed initiation of therapy is a strong predictor of mortality in cases of tuberculous meningitis, clinicians must consider tuberculosis in the differential diagnosis of the HIV-infected individual with acute or chronic lymphocytic meningitis. Additional treatment considerations for HIV-infected individuals include the timing of initiation of antiretroviral therapy, the potential for drug-drug interactions, and the role of adjunctive corticosteroid therapy.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19589299      PMCID: PMC3131531          DOI: 10.1007/s11904-009-0019-7

Source DB:  PubMed          Journal:  Curr HIV/AIDS Rep        ISSN: 1548-3568            Impact factor:   5.071


  48 in total

1.  Tuberculous meningitis among adults with and without HIV infection. Experience in an urban public hospital.

Authors:  V K Yechoor; W X Shandera; P Rodriguez; T R Cate
Journal:  Arch Intern Med       Date:  1996 Aug 12-26

2.  The spectrum of meningitis in a population with high prevalence of HIV disease.

Authors:  A Bergemann; A S Karstaedt
Journal:  QJM       Date:  1996-07

3.  A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection.

Authors:  P A Selwyn; D Hartel; V A Lewis; E E Schoenbaum; S H Vermund; R S Klein; A T Walker; G H Friedland
Journal:  N Engl J Med       Date:  1989-03-02       Impact factor: 91.245

4.  Tuberculous meningitis. Clinical characteristics and comparison with cryptococcal meningitis in patients with human immunodeficiency virus infection.

Authors:  J Sánchez-Portocarrero; E Pérez-Cecilia; A Jiménez-Escrig; P Martin-Rabadán; V Roca; M Ruiz Yague; J Romero-Vivas; E Palau; J J Picazo
Journal:  Arch Neurol       Date:  1996-07

5.  Cerebrospinal fluid drug concentrations and the treatment of tuberculous meningitis.

Authors:  G A Ellard; M J Humphries; B W Allen
Journal:  Am Rev Respir Dis       Date:  1993-09

Review 6.  Tuberculosis and HIV infection in sub-Saharan Africa.

Authors:  K M De Cock; B Soro; I M Coulibaly; S B Lucas
Journal:  JAMA       Date:  1992 Sep 23-30       Impact factor: 56.272

7.  Tuberculous meningitis in patients infected with the human immunodeficiency virus.

Authors:  J Berenguer; S Moreno; F Laguna; T Vicente; M Adrados; A Ortega; J González-LaHoz; E Bouza
Journal:  N Engl J Med       Date:  1992-03-05       Impact factor: 91.245

8.  Tuberculous meningitis in patients with and without human immunodeficiency virus infection.

Authors:  M P Dubé; P D Holtom; R A Larsen
Journal:  Am J Med       Date:  1992-11       Impact factor: 4.965

9.  Tuberculous meningitis: a 30-year review.

Authors:  S J Kent; S M Crowe; A Yung; C R Lucas; A M Mijch
Journal:  Clin Infect Dis       Date:  1993-12       Impact factor: 9.079

Review 10.  Paradoxical enlargement or development of intracranial tuberculomas during therapy: case report and review.

Authors:  B Afghani; J M Lieberman
Journal:  Clin Infect Dis       Date:  1994-12       Impact factor: 9.079

View more
  23 in total

1.  MRI findings in children with tuberculous meningitis: a comparison of HIV-infected and non-infected patients.

Authors:  Gerrit Dekker; Savvas Andronikou; Ronald van Toorn; Shaun Scheepers; Andrew Brandt; Christelle Ackermann
Journal:  Childs Nerv Syst       Date:  2011-04-15       Impact factor: 1.475

2.  Delta-like 1 protein, vitamin D binding protein and fetuin for detection of Mycobacterium tuberculosis meningitis.

Authors:  Nathan C Bahr; Ryan Halupnick; Grace Linder; Reuben Kiggundu; Henry W Nabeta; Darlisha A Williams; Abdu K Musubire; Bozena M Morawski; Srinand Sreevatsan; David B Meya; Joshua Rhein; David R Boulware
Journal:  Biomark Med       Date:  2018-06-01       Impact factor: 2.851

3.  Cerebrospinal T-cell responses aid in the diagnosis of tuberculous meningitis in a human immunodeficiency virus- and tuberculosis-endemic population.

Authors:  Vinod B Patel; Ravesh Singh; Cathy Connolly; Yacoob Coovadia; Abdool K C Peer; Priyashini Parag; Victoria Kasprowicz; Alimuddin Zumla; Thumbi Ndung'u; Keertan Dheda
Journal:  Am J Respir Crit Care Med       Date:  2010-05-04       Impact factor: 21.405

4.  Comparison of amplicor and GeneXpert MTB/RIF tests for diagnosis of tuberculous meningitis.

Authors:  Vinod B Patel; Cathy Connolly; Ravesh Singh; Laura Lenders; Brian Matinyenya; Grant Theron; Thumbi Ndung'u; Keertan Dheda
Journal:  J Clin Microbiol       Date:  2014-07-23       Impact factor: 5.948

Review 5.  HIV and tuberculosis: a deadly human syndemic.

Authors:  Candice K Kwan; Joel D Ernst
Journal:  Clin Microbiol Rev       Date:  2011-04       Impact factor: 26.132

Review 6.  Adjunctive tests for diagnosis of tuberculosis: serology, ELISPOT for site-specific lymphocytes, urinary lipoarabinomannan, string test, and fine needle aspiration.

Authors:  Jacqueline M Achkar; Stephen D Lawn; Mahomed-Yunus S Moosa; Colleen A Wright; Victoria O Kasprowicz
Journal:  J Infect Dis       Date:  2011-11-15       Impact factor: 5.226

7.  Randomized trial of minocycline in the treatment of HIV-associated cognitive impairment.

Authors:  Noeline Nakasujja; Sachiko Miyahara; Scott Evans; Anthony Lee; Seggane Musisi; Elly Katabira; Kevin Robertson; Allan Ronald; David B Clifford; Ned Sacktor
Journal:  Neurology       Date:  2012-12-26       Impact factor: 9.910

8.  Central Nervous System Tuberculosis (CNS-TB) in treated HIV-infected adults in Tikur Anbessa Specialized Hospital, Ethiopia: A cross sectional study.

Authors:  Biniyam A Ayele; Wondwossen Amogne
Journal:  J Clin Tuberc Other Mycobact Dis       Date:  2021-06-08

9.  Tuberculous meningitis: presentation, diagnosis and outcome in hiv-infected patients at the douala general hospital, cameroon: a cross sectional study.

Authors:  Henry Namme Luma; Benjamin Clet Nguenkam Tchaleu; Bertrand Hugo Mbatchou Ngahane; Elvis Temfack; Marie Solange Doualla; Marie Patrice Halle; Henry Achu Joko; Sinata Koulla-Shiro
Journal:  AIDS Res Ther       Date:  2013-06-11       Impact factor: 2.250

10.  Stroke in a Patient with Tuberculous Meningitis and HIV Infection.

Authors:  Maria Bruna Pasticci; Maurizio Paciaroni; Piero Floridi; Enisia Cecchini; Franco Baldelli
Journal:  Mediterr J Hematol Infect Dis       Date:  2013-02-18       Impact factor: 2.576

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.